Kamaljit Kaur

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 7

Top Venues

Molecular pharmaceutics

Journal of medicinal chemistry

Pharmaceutics

Bioconjugate chemistry

Chapman University

Case Western Reserve University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Chapman University

United States

Associate Professor :: School of Pharmacy

University of Alberta

Canada

Assistant and Associate Professor :: Faculty of Pharmacy and Pharmaceutical Sciences

Education History

Case Western Reserve University

United States

PHD :: Chemistry

Indian Institute of Technology Kanpur

India

MSC :: Chemsitry

Publications

Elmira Ziaei, Igor Moura de Paiva, Shih-Jing Yao, Nasim Sarrami, Parnian Mehinrad, Justine Lai, Afsaneh Lavasanifar, Kamaljit Kaur
Peptide-Drug Conjugate Targeting Keratin 1 Inhibits Triple-Negative Breast Cancer in Mice. Molecular pharmaceutics (2023)
Shirley Tong, Shaban Darwish, Hanieh Hossein Nejad Ariani, Kate Alison Lozada, David Salehi, Maris A Cinelli, Richard B Silverman, Kamaljit Kaur, Sun Yang
A Small Peptide Increases Drug Delivery in Human Melanoma Cells. Pharmaceutics 14 (5) (2022)
Azam Saghaeidehkordi, Shiuan Chen, Sun Yang, Kamaljit Kaur
Evaluation of a Keratin 1 Targeting Peptide-Doxorubicin Conjugate in a Mouse Model of Triple-Negative Breast Cancer. Pharmaceutics 13 (5) (2021)
Mona Alas, Azam Saghaeidehkordi, Kamaljit Kaur
Peptide-Drug Conjugates with Different Linkers for Cancer Therapy. Journal of medicinal chemistry 64 (1) (2020)
Elmira Ziaei, Azam Saghaeidehkordi, Cassandra Dill, Innokentiy Maslennikov, Shiuan Chen, Kamaljit Kaur
Targeting Triple Negative Breast Cancer Cells with Novel Cytotoxic Peptide-Doxorubicin Conjugates. Bioconjugate chemistry 30 (12) (2019)
Rania Soudy, Hashem Etayash, Kamran Bahadorani, Afsaneh Lavasanifar, Kamaljit Kaur
Breast Cancer Targeting Peptide Binds Keratin 1: A New Molecular Marker for Targeted Drug Delivery to Breast Cancer. Molecular pharmaceutics 14 (3) (2017)
Yogita Raghuwanshi, Hashem Etayash, Rania Soudy, Igor Paiva, Afsaneh Lavasanifar, Kamaljit Kaur
Proteolytically Stable Cyclic Decapeptide for Breast Cancer Cell Targeting. Journal of medicinal chemistry 60 (12) (2017)

Kamaljit Kaur.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kamaljit Kaur